Compare Barclays PLC (BCS) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Barclays PLC vs Revvity Inc — how do they compare? Barclays PLC trades at $28.1 (market cap $94.10B), while Revvity Inc trades at $115.76 (market cap $12.94B). The key difference: Barclays PLC is far larger — about 7.3× Revvity Inc's market cap, and Barclays PLC pays the higher dividend (2.18%). Which is the better fit depends on your goals.
| BCS | RVTY | |
|---|---|---|
Market Cap | $94.10B | $12.94B |
Sector | Financials | Technology |
52-Week High | $28.56 | $117.75 |
52-Week Low | $19.36 | $82.26 |
Dividend Yield | 2.18% | 0.24% |
Enterprise Value | — | $15.26B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RVTY trades at $114.66, up 0.37% today, with a bullish technical signal and strong earnings beats in recent quarters. The stock shows robust fundamentals with a 54.98% gross margin and $241.20M net income for 2025, supported by positive news including product launches and raised 2026 guidance. Analyst consensus is a buy with a $120.50 price target, indicating potential upside from current levels.
Outlook remains positive due to consistent earnings outperformance and innovation in diagnostics, but risks include high P/E valuation and competitive pressures. Investors may find opportunity in sustained margin strength and AI integration, though macroeconomic sensitivity warrants caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Barclays PLC
Barclays is a universal bank headquartered in the United Kingdom. It operates via two principal segments
Read more on BCS →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
